Engineering information releases enhanced ChemVillage™
Technology upgrade offers significant user enhancements.
Hoboken, NJ, 18 June 2004 – Elsevier Engineering Information announces the latest release of the ChemVillage discovery platform, enhancing the way users access chemistry content. With focus on applied chemistry research, ChemVillage offers access to high quality text-based resources including bibliographic databases Beilstein Abstracts® and Chimica®, and the leading business news source covering the global chemicals industry, Chemical Business NewsBase®.
This latest release enhances the research process through significant upgrades to the platform’s underlying technology. The FAST search engine has been implemented to deliver standard bearing search and retrieval speeds. Intuitive functional enhancements include multiple database searches with user-controlled de-duplication, personalized searches and extensive full-text linking options. Unlimited email alerting offers all users the ability to receive weekly updates on record additions in their area of interest. All upgrades enhance researcher driven discovery with tools designed to simplify chemistry research.
“Chemists, researchers and industry professionals require sensible means to access chemistry related research,” explains Bryan Vickery, Engineering Information’s Vice President of Chemistry Publishing. “The major technological upgrades to ChemVillage provide users with a far more robust environment to conduct their research – Speeding discovery and improving the entire information gathering process.”
About Elsevier Engineering Information
Elsevier Engineering Information is a leading provider of information solutions and discovery tools that meet the needs of the engineering and applied physical science communities. Elsevier Engineering Information publishes six bibliographic databases including Compendex®, Chimica®, Chemical Business NewsBase® and PaperChem®, and provides the online discovery platforms Engineering Village 2™ and ChemVillage™.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
